Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

[Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].

Chen DA, Yang XZ, Zhang PH, Li GS, Chang DG.

Zhonghua Nan Ke Xue. 2013 Jun;19(6):527-30. Chinese.

PMID:
23862231
2.

Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.

Liu L, Li Q, Han P, Li X, Zeng H, Zhu Y, Wei Q.

Urology. 2009 Aug;74(2):340-4. doi: 10.1016/j.urology.2009.02.064. Epub 2009 May 22.

PMID:
19464042
3.

[Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].

Gao WJ, Wang YM, Wang CH, Yang XK, Wan L, Li WP.

Zhonghua Nan Ke Xue. 2013 Apr;19(4):315-20. Chinese.

PMID:
23678709
4.

[The relationship between anaphylatoxin C3a and benign prostatic hyperplasia with inflammation].

Xie L, Cheng SL, Li YZ, Liu LR, Han P, Chen N, Wei Q, Zhou Q.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;42(5):642-5. Chinese.

PMID:
22007489
5.
6.

[LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].

Huang XH, Qin B, Liang YW, Wu QG, Li CZ, Wei GS, Ji HC, Liang YB, Chen HQ, Guan T.

Zhonghua Nan Ke Xue. 2013 Jan;19(1):35-9. Chinese.

PMID:
23469659
7.

[Relationship between interleukin-8 levels in expressed prostatic secretion and expressions of bFGF and Bcl-2 in benign prostatic hyperplasia].

Song W, Li DY, Yuan HC, Gu ZH, Shao JL, Wang X.

Zhonghua Yi Xue Za Zhi. 2016 Jan 12;96(2):104-7. doi: 10.3760/cma.j.issn.0376-2491.2016.02.006. Chinese.

PMID:
26792691
8.

[Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].

Zhang HT, Xu Y, Chang JW, Zhang ZH, Liu RL, Ma BJ.

Zhonghua Nan Ke Xue. 2012 Mar;18(3):208-11. Chinese.

PMID:
22474983
9.

Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.

Engelhardt PF, Seklehner S, Brustmann H, Lusuardi L, Riedl CR.

Scand J Urol. 2015 Apr;49(2):120-6. doi: 10.3109/21681805.2014.971427. Epub 2014 Nov 3.

PMID:
25363611
10.

[Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].

Chang DG, Li GS, Zhang PH, Wu TL, Mei XF, Cao J, Gao P.

Zhonghua Nan Ke Xue. 2010 Sep;16(9):830-3. Chinese.

PMID:
21171270
11.

[A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].

Wu XJ, Yang LY, Zhang XZ.

Zhonghua Nan Ke Xue. 2008 Jun;14(6):527-9. Chinese.

PMID:
18649752
12.

The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.

Al-Maghrebi M, Kehinde EO, Al-Mulla F, Anim JT.

Ann Saudi Med. 2012 May-Jun;32(3):262-8. doi: 10.5144/0256-4947.2012.262.

13.

Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.

Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G, Fibbi B, Colli E, Maggi M, Adorini L.

Eur Urol. 2007 Feb;51(2):524-33; discussion 533. Epub 2006 Jul 28.

PMID:
16905241
14.

Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.

Edlin RS, Heyns CF, Van Vuuren SP, Zarrabi AD.

S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.

PMID:
23217554
15.

[Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].

Yang GQ, Li SW, Zheng H, Zhang WB, Hu WL, Zheng XM.

Zhonghua Nan Ke Xue. 2009 Apr;15(4):314-7. Chinese.

PMID:
19472903
16.

Impacts of histological prostatitis on sexual function and lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Wang GC, Zheng JH, Yang B, Che JP, Yan Y, Geng J, Liu M, Huang JH, Xia SQ, Peng B.

Urology. 2013 Nov;82(5):1094-7. doi: 10.1016/j.urology.2013.06.010. Epub 2013 Jul 31.

PMID:
23915513
17.

Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.

Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, Schaeffer AJ.

Urology. 2000 Dec 20;56(6):1025-9.

PMID:
11113752
18.

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

Robert G, Descazeaud A, Nicolaïew N, Terry S, Sirab N, Vacherot F, Maillé P, Allory Y, de la Taille A.

Prostate. 2009 Dec 1;69(16):1774-80. doi: 10.1002/pros.21027.

19.

Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.

Bozdar HR, Memon SR, Paryani JP.

J Ayub Med Coll Abbottabad. 2010 Oct-Dec;22(4):194-6.

PMID:
22455296
20.

[Benign prostate hyperplasia with chronic prostatitis: an update].

Ma Y, Zhang WL.

Zhonghua Nan Ke Xue. 2010 Jul;16(7):646-50. Review. Chinese.

PMID:
20873602

Supplemental Content

Support Center